Cardio-oncology: Implications for Clinical Practice for Women
- PMID: 36112292
- DOI: 10.1007/s11886-022-01779-1
Cardio-oncology: Implications for Clinical Practice for Women
Abstract
Purpose of review: Clinical cardio-oncology considerations specific to women span across many areas and are particularly relevant for management of patients with sex-specific cancers, such as breast cancer.
Recent findings: Major improvement in breast cancer survivorship over the last decade and the recognition of CV disease as the second leading cause of death among survivors point to the relevance of long-term cardiovascular (CV) safety. This review summarizes the CV effects associated with multimodality breast cancer treatments and contemporary approach to CV risk stratification, prevention, early detection, monitoring, and management at the time of cancer diagnosis, during and after completion of treatment. We highlight the growing role of a multidisciplinary, team-based approach for comprehensive CV and oncology care through the entire cancer treatment continuum, from diagnosis through survivorship.
Keywords: Breast cancer; Cardio-oncology; Cardiotoxicity; Heart failure; Multidisciplinary approach; Women.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
-
- Barac A, Murtagh G, Carver JR, Chen MH, Freeman AM, Herrmann J, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015;65:2739–46. - DOI
-
- • Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2022;43:280–99. This International Cardio-Oncology Society (IC-OS) consensus statement presents a thorough review of the CV toxicities and their definitions. - DOI
-
- Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4: e214708. - DOI
-
- Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, et al. All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. J Natl Cancer Inst. 2021;113:137–45. - DOI
-
- Liu EE, Suthahar N, Paniagua SM, Wang D, Lau ES, Li SX, et al. Association of cardiometabolic disease with cancer in the community. JACC CardioOncol. 2022;4:69–81. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials